Skip to main content

Table 3 Antithrombotic treatment at discharge

From: Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry

Patient characteristics

Sinus rhythm at admission

n = 119

Atrial fibrillation at admission

n = 212

p

   

0.90

No antithrombotic agent

3 (2.5)

9 (4.2)

 

Single antiplatelet therapy

34 (28.6)

59 (27.8)

 

Dual-antiplatelet therapy

51 (42.9)

95 (44.8)

 

Anticoagulation

19 (16.0)

32 (15.1)

 

Anticoagulation + antiplatelet therapy

12 (10.1)

17 (8.0)